The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Yusef Yu.N.

Krasnov Research Institute of Eye Diseases;
I.M. Sechenov First Moscow State Medical University (Sechenov University)

Sheludchenko V.M.

Krasnov Research Institute of Eye Diseases

Budzinskaya M.V.

Krasnov Research Institute of Eye Diseases

Smirnova T.V.

Krasnov Research Institute of Eye Diseases

Kozlovskaya N.L.

Peoples’ Friendship University of Russia named after Patrice Lumumba

Durzhinskaya M.H.

Krasnov Research Institute of Eye Diseases

Krasnolutskaya E.I.

Krasnov Research Institute of Eye Diseases

Kuchieva A.M.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Retinopathy associated with thrombotic microangiopathy of mixed origin (case report)

Authors:

Yusef Yu.N., Sheludchenko V.M., Budzinskaya M.V., Smirnova T.V., Kozlovskaya N.L., Durzhinskaya M.H., Krasnolutskaya E.I., Kuchieva A.M.

More about the authors

Journal: Russian Annals of Ophthalmology. 2024;140(6): 90‑99

Read: 1073 times


To cite this article:

Yusef YuN, Sheludchenko VM, Budzinskaya MV, et al. . Retinopathy associated with thrombotic microangiopathy of mixed origin (case report). Russian Annals of Ophthalmology. 2024;140(6):90‑99. (In Russ.)
https://doi.org/10.17116/oftalma202414006190

Recommended articles:
Masks of autoimmune diseases: a multidisciplinary approach to the problem. Journal of Respiratory Medi­cine. 2025;(1):58-64

References:

  1. Bommer M, Wolfle-Guter M, Bohl S, Kuchenbauer F. The differential diagnosis and treatment of thrombotic microangiopathies. Dtsch Arztebl Int. 2018;115(19):327-334.  https://doi.org/10.3238/arztebl.2018.0327
  2. Sakari Jokiranta T. HUS and atypical HUS. Blood. 2017;129(21):2847-2856. https://doi.org/10.1182/blood-2016-11-709865
  3. Hughes GRV, Harris EN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol. 1986;13(3):486-489. 
  4. Gomez-Puerta JA, Cervera R. Diagnosis and classification of the antiphospholipid syndrome. J Autoimmun. 2014;48-49:20-25.  https://doi.org/10.1016/j.jaut.2014.01.006
  5. Boulestreau R, van den Born BH, Lip GYH, Gupta A. Malignant hypertension: current perspectives and challenges. J Am Heart Assoc. 2022;11(7): e023397. https://doi.org/10.1161/JAHA.121.023397
  6. Brocklebank V, Wood KM, Kavanagh D. Thrombotic microangiopathy and the kidney. Clin J Am Soc Nephrol. 2018;13(2):300-317.  https://doi.org/10.2215/CJN.00620117
  7. Hayreh SS, Servais GE, Virdi PS. Fundus lesions in malignant hypertension. VI. Hypertensive choroidopathy. Ophthalmology. 1986;93(11):1383-1400. https://doi.org/10.1016/s0161-6420(86)33554-1
  8. Hammond S, Wells JR, Marcus DM, Prisant LM. Ophthalmoscopic findings in malignant hypertension. J Clin Hypertens. 2006;8(3):221-223.  https://doi.org/10.1111/j.1524-6175.2005.04147.x
  9. Fursova AZh, Vasilyeva MA, Tarasov MS, Zubkova MY, Derbeneva AS, Nikulich IF, Gamza YuA. Features of structural and microvascular changes of the choroid in angioretinopathy of various etiologies. Russian Annals of Ophthalmology=Vestnik oftal’mologii. 2022;138(2):47-56 (In Russ.). https://doi.org/10.17116/oftalma202213802147
  10. Fursova AZh, Derbeneva AS, Vasilyeva MA, Tarasov MS, Nikulich IF, Galkina EV. Development, clinical manifestations and diagnosis of retinal changes in chronic kidney disease. Russian Annals of Ophthalmology=Vestnik oftal’mologii. 2021;137(1):107-114 (In Russ.). https://doi.org/10.17116/oftalma2021137011107
  11. Uludag G, Onghanseng N, Tran ANT, Hassan M, Halim MS, Sepah YJ, Do DV, Nguyen QD. Current concepts in the diagnosis and management of antiphospholipid syndrome and ocular manifestations. J Ophthalm Inflam Infect. 2021;11(1):11.  https://doi.org/10.1186/s12348-021-00240-8
  12. Leo-Kottler B, Klein R, Berg PA, Zrenner E. Ocular symptoms in association with antiphospholipid antibodies. Graefe´s Arch Clin Exp Ophthalmol. 1998;236(9):658-668.  https://doi.org/10.1007/s004170050138
  13. Utz VM, Tang J. Ocular manifestations of the antiphospholipid syndrome. Brit J Ophthalmol. 2011;95(4):454—459.  https://doi.org/10.1136/bjo.2010.182857
  14. Ahn SJ, Woo SJ, Park KH. Retinal and choroidal changes with severe hypertension and their association with visual outcome. Invest Ophthalmol Vis Sci. 2014;55(12):7775-7785. https://doi.org/10.1167/iovs.14-14915
  15. Akay F, Gundogan FC, Yolcu U, Toyran S, Uzun S. Choroidal thickness in systemic arterial hypertension. Eur J Ophthalmol. 2016;26(2):152-157.  https://doi.org/10.5301/ejo.5000675
  16. Kim YH, Chung Y-R, Kim C, Lee K, Lee WK. The association of pachydrusen characteristics with choroidal thickness and patient’s age in polypoidal choroidal vasculopathy versus central serous chorioretinopathy. Int J Mol Scie. 2022;23(15):8353. https://doi.org/10.3390/ijms23158353
  17. Yung M, Klufas MA, Sarraf D. Clinical applications of fundus autofluorescence in retinal disease. Int J Retina Vitr. 2016;2:12.  https://doi.org/10.1186/s40942-016-0035-x
  18. Ramezani A, Saberian P, Soheilian M, Parsa SA, Kamali HK, Entezari M, Shahbazi MM, Yaseri M. Fundus autofluorescence in chronic essential hypertension. J Ophthalm Vis Res. 2014;9(3):334-338.  https://doi.org/10.4103/2008-322X.143372
  19. Kishi S, Tso MO, Hayreh SS. Fundus lesions in malignant hypertension. I. A pathologic study of experimental hypertensive choroidopathy. Arch Ophthalmol. 1985;103(8):1189-1197. https://doi.org/10.1001/archopt.1985.01050080101029
  20. de Venecia G, Wallow I, Houser D, Wahlstrom M. The eye in accelerated hypertension. I. Elschnig’s spots in nonhuman primates. Arch Ophthalmol. 1980;98(5):913-918.  https://doi.org/10.1001/archopt.1980.01020030907021
  21. Nakamura A, Yokoyama T, Kodera S, Zhang D, Hirose S, Shirai T, Kanai A. Ocular fundus lesions in systemic lupus erythematosus model mice. Jap J Ophthalmol. 1998;42(5):345-351.  https://doi.org/10.1016/s0021-5155(98)00023-9
  22. Ijuin N, Tsujinaka H, Hirai H, Jimura H, Nakao S, Yamashita M, Nishi T, Ueda T, Ogata N. Clinical implications of pachyvessels in polypoidal choroidal vasculopathy. BMC Ophthalmol. 2020 Apr 29;20(1):170.  https://doi.org/10.1186/s12886-020-01443-8
  23. Goyal JL, Gupta A, Gandhi P. Ocular manifestations in renal diseases. Indian J Ophthalmol. 2023 Aug;71(8):2938-2943. https://doi.org/10.4103/IJO.IJO_3234_22

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.